Literatur
- 1
Von Minckwitz G.
Memorandum zur praktischen Umsetzung translationaler Forschung beim Mammakarzinom.
Biedenkopf 2005.
Breast Care.
2006;
1
49-50
- 2 Homepage der AGO Kommission Translationale Forschung: http://134.99.204.130/trafo/index.html
.
- 3 http://www.germanbreastgroup.de/geparquattro/design.html
- 4
Huober J, Jackisch C, Untch M, Möbus V, Wallwiener D, Kaufmann M, von Minkwitz G.
Adjuvanter Einsatz von Trastuzumab (Herceptin) beim primären Mammakarzinom - aktuelle
Datenlage und Bewertung der Stellungnahme des Kompetenz Centrums Onkologie des MDK
Nordrhein.
Zentralblatt Gynäkol.
2006;
128
30-37
- 5 http://www.ago-online.de
- 6
Kaufmann M, Hortobagyi G N, Goldhirsch A, Scholl S, Makris A, Valagussa P, Blohmer J U,
Eiermann W, Jackesz R, Jonat W, Lebeau A, Loibl S, Miller W, Semiglazov V, Smith R,
Seeber S, Souchon R, Stearns V, Untch M, von Minckwitz G.
Recommendations from an international expert panel on the use of neoadjuvant (primary)
systemic treatment of operable breast cancer: an update.
J Clin Oncol.
2006;
24
1940-1949
- 7
Finn R S, Wilson C A, Dering J, Ginther C, Cook A M, Glaspy P, Venkatesen N, Raab G,
Pawlicki M, Gerber B, Pinter T, Eiermann W, von Minckwitz G, Mackey J, Reese D, Kiger C,
French T, Barrett I, Chang K M, South M, Slamon D J.
Results of BCIRG 103: a presurgical study to evaluate molecular alterations that occur
in human breast cancer tissue after short-term exposure to gefitinib.
Breast Canc Res Treat.
2005;
94
abst 4079
- 8
von Minckwitz G, Blohmer J U, Loehr A, Raab G, Eidtmann H, Hilfrich J, Gerber B, Huober J,
Costa S D, Jackisch C, Loibl S, Schickling O, Zuna I, Kaufmann M.
German Breast Group Comparison of docetaxel/doxorubicin/cyclophosphamide (TAC) versus
vinorelbine/capecitabine (NX) in patients non-responding to 2 cycles of neoadjuvant
TAC chemotherapy-first results of the phase III GEPARTRIO-Study by the German Breast
Group.
Breast Canc Res Treat.
2002;
94
abst 38
- 9
von Minckwitz G, Blohmer J, Vogel P, Hanusch C, Eidtmann H, Hilfrich J, Gerber B,
Huober J, Costa S, Kaufmann M.
Comparison of neoadjuvant 6 vs. 8 cycles of docetaxel/doxorubicin/cyclophosphamide
(TAC) in patients early responding to TACx2-the GEPARTRIO Study.
J Clin Onco.
2006; 24;
18 S
576
- 12 http://www.germanbreastgroup.de
- 10
von Minckwitz G, Sinn H P, Petrich S. et al .
Clinical response after two cycles is superior to Her2, Ki67, p 53, and bcl2 in independently
predicting a pathological complete response after peroperative chemotherapy in patients
with operable carcinoma of the breast.
Eur J Cancer.
2002;
S 3
S107
- 11
Mutter G L, Zahrieh D, Liu C, Neuberg D, Finkelstein D, Baker H E, Warrington J A.
Comparison of frozen and RNALater solid tissue storage methods for use in RNA expression
microarrays.
BMC Genomics.
2004;
5
88
Prof. Dr. Gunter von Minckwitz
German Breast Group/Universitäts-Frauenklinik Frankfurt
Schleussnerstraße 42
63263 Neu-Isenburg
Email: minckwitz@germanbreastgroup.de
